Skip to content
Biodatica
Start free

Precision Epigenomics Inc

TUCSON, AZ

Oncologyliquid biopsyFormed
Compare Sign in to watch

What changed

$265k raise filed (Form D)

9mo agoRaise filed (Form D)Sep 23, 2025Source filing (opens the source filing in a new tab)

Momentum

50no change

Momentum 50 out of 100, unchanged since the last recompute.

Some recent activity, at a steady rate.

Runway (estimate)

~0months

The model puts this company near the end of its last raise.

Stage

Formed

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

15 pre-ticker oncology companies at Formed

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Filing

    Form D · $265k

    Sep 23, 2025

    Precision Epigenomics Inc · private raise, self-reported by the issuer

    SEC EDGAR · 0001062993-25-015757 (opens the source filing in a new tab)

  2. Grant

    R01 · $663k · non-dilutive

    Mar 11, 2025

    MASSACHUSETTS GENERAL HOSPITAL · PI MILLER, MILES A · NCI · award ends Feb 28, 2030 · Imaging radiation-enhanced drug delivery for safer and more effective chemoradiotherapy

    NIH RePORTER · NIH RePORTER 11127053 (opens the source filing in a new tab)

  3. Grant

    R01 · $644k · non-dilutive

    Mar 11, 2025

    MASSACHUSETTS GENERAL HOSPITAL · PI MILLER, MILES A · NCI · award ends Feb 28, 2030 · Expanding the therapeutic window of chemoradiation through radiation-responsive nanoparticle drug depots

    NIH RePORTER · NIH RePORTER 11083240 (opens the source filing in a new tab)

  4. Grant

    R44 · $70k · non-dilutive

    Feb 1, 2025

    PRECISION EPIGENOMICS, INC. · PI NELSON, MARK ANTHONY · NCI · award ends Jul 31, 2026 · Development of a Molecular Assay to Diagnose Malignant Pleural Effusions

    NIH RePORTER · NIH RePORTER 11196648 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources